Partnering with Kiss Communications, Medi-Mation's work on Altermune's Innovative Technology Animation has been nominated for the 'best use of animation' at the Roses Creative Awards. Winners to be announced in May, we'll be there!
Welcome to our new site!
A bit later than hoped but we got there in the end!
I hope you enjoy looking around and we look forward to hearing your thoughts.
Rajeev
Medi-Mation is proud to announce it has completed work on a series of animations for Myeloma UK. The animations help to describe key aspects of myeloma, its treatment and the complications it can cause.
The 2-3 minute 3D animations have been developed for patients and their families to improve their understanding of myeloma. You can view some of them here and also on Myeloma UK's site. They have already been a huge success and we will be producing more this year.
Medi-Mation has completed work on Dorling Kindersley's latest title, Supershark. This title uncovers the secrets of the oceans by exploring a remarkable array of sharks and sea creatures in really impressive 3D renderings of their external, internal and X-ray structures. Sneak peek on the left and more to come when the book is released in June 2015.
Working with ICC Lowe, Medi-Mation recently created a series of illustrations to visualise the technology underpinning Johnson & Johnson's latest Acuvue contact lenses. Very conceptual in nature, this was a really challenging project which pushed us all but resulted in some beautiful illustrations.
Working with GlaxoSmithKline, Medi-Mation created a series of animations to show how Aquafresh's new formulations help to protect teeth from sugar acid erosion. Primarily created to show their sales force, the animations are now rolling out to a wider audience. You can view one of them in our Work section.
Working with KISS Communications and Altermune, Medi-Mation created a detailed mode of action animation to show how its new Alphamer technology can be used to target antibiotic-resistant gram-negative bacteria which are a significant and increasing cause of infection and mortality in hospitals. In addition to the mechanism of action, the animation covered the drug selection and optimisation process which we visualised in a fun and engaging way.
Working with KISS Communications and Agalimmune, Medi-Mation created an animation demonstrating the mechanism of action of its new Alphaject technology which is designed to harness the power of the body's own immune response to destroy cancer cells whilst also providing a long lasting immunity. Whilst initial applications will be for melanoma, the technology is able to work with a range of tumour types and holds great promise for the future.
